Mar 1, 2019

Oncolytics Biotech(R) to Host Conference Call to Discuss Year End Financial Results and Operational Highlights

Feb 27, 2019

Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR

Feb 11, 2019

Oncolytics Biotech(R) Announces Spanish Regulatory Approval of AWARE-1 Window of Opportunity Study in Breast Cancer

Feb 4, 2019

Oncolytics Biotech(R) to Present at the 21st Annual BIO CEO & Investor Conference

Dec 12, 2018

Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and the Checkpoint Inhibitor Opdivo® in Multiple Myeloma

Dec 3, 2018

Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasome Inhibitor in Poster Presentation at the 60th American Society of Hematology Annual Meeting & Exposition

Nov 29, 2018

Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical Officer

Nov 26, 2018

Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytruda® in Advanced Pancreatic Cancer

Nov 13, 2018

Oncolytics Biotech® Announces Attendance of Upcoming Conferences

Nov 12, 2018

Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update